CIK 0001559053 · Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 011-353-1-236-2500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 218,667 | ||
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Option exercise 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,337 | $46.51 | $202K | 663 |
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −663 | $47.29 | $31K | 0 |
| 2023-10-04 | Karp Carol D. Chief Regulatory Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 45,000 | ||
| 2023-09-27 | Malecek Michael J Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $10.27 | $51K | 5,000 |
| 2023-09-27 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −4,596 | $47.29 | $217K | 404 |
| 2023-09-27 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −404 | $48.31 | $20K | 0 |
| 2023-09-27 | Malecek Michael J Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 90,000 | ||
| 2023-09-19 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $15.04 | $75K | 5,000 |
| 2023-09-19 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −5,000 | $52.36 | $262K | 0 |
| 2023-09-19 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 481 | ||
| 2023-09-13 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $24.90 | $50K | 2,000 |
| 2023-09-13 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −2,000 | $55.48 | $111K | 0 |
| 2023-09-13 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 192,000 | ||
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +4,000 | $11.12 | $44K | 4,000 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −3,886 | $55.48 | $216K | 114 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −114 | $55.96 | $6K | 0 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 222,667 | ||
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Option exercise 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
Page 8 of 9 · 172 trades